Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2017, Vol. 37 Issue (11): 123-131    DOI: 10.13523/j.cb.20171117
    
Development and Application of L-Asparaginase with Better Performance and Advances in Recombinant Expression
ZENG Jie
Jiangsu Hengrui Medicine Co., Ltd., National Engineering Technology Research Center of Targeted Drugs, China, Lianyungang 222047, China
Download: HTML   PDF(493KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  L-asparaginase is an anti-neoplastic agent, used in acute lymphoblastic leukemia(ALL) and lymphosarcoma chemotherapy. However, the application in clinic therapeutics is obstructed by its high costs of production. Nevertheless, the expression system of recombinant proteins have solved this problem perfectly. The intrinsic low-rate glutaminase activity of L-asparaginase, however, causes serious side-effects. In addition, L-asparaginase from bacterial origin can cause hypersensitivity in the long-term used, leading to allergic reactions and anaphylaxis. The search for new L-asparaginase sources, which shows less adverse effects, has become the focus of scholar studies. A review of recent progress in development of L-asparaginase with better performance are presented. Furthermore, the successful expression of recombinant L-asparaginase were aslo summarized and analyzed, and the potential perspective of L-asparaginase to be used in clinic therapeutics and food industry was discussed.

Key wordsReducing adverse effects      Acrylamide      L-asparaginase      Recombinant expression      Acute lymphoblastic leukemia     
Received: 02 May 2017      Published: 15 November 2017
ZTFLH:  Q81  
Cite this article:

ZENG Jie. Development and Application of L-Asparaginase with Better Performance and Advances in Recombinant Expression. China Biotechnology, 2017, 37(11): 123-131.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.20171117     OR     https://manu60.magtech.com.cn/biotech/Y2017/V37/I11/123

[1]   Kidd J G. Regression of transplanted lymphomas induced in vivo by means of normal guinea pig serum. I. Course of transplanted cancers of various kinds in mice and rats given guinea pig serum,horse serum or rabbit serum. Journal of Experimental Medicine,1953,98(6):565-582.
[2]   Broome J D. Evidence that the L-asparaginase activity of guinea pig serum is responsible for its anti-lymphoma effects. Nature,1961,191:1114-1115.
[3]   Mashburn L T,Wriston J C. Tumor inhibitory effect of L-asparaginase from Escherichia coli. Archives of Biochemistry and Biophysics,1964,105:450-452.
[4]   Campbell H A,Mashburn L T,Boyse E A,et al.Two Asparaginase from Escherichia coli B,their separation,purification and antitumor property. Biochemistry,1967,6(3):721-730.
[5]   Swain A L,Jaskolski M,Housset D,et al. Crystal structure of Escherichia coli L-asparaginase,an enzyme used in cancer therapy. Proceedings of the National Academy of Sciences of the United States of America,1993,90(4):1474-1478.
[6]   Ahmad N,Pandit N P,Maheshwari S K. L-asparaginase gene-a therapeutic approach towards drugs for cancer cell. International Journal of Biosciences,2012,2(4):1-11.
[7]   Jha S K,Pasrija D,Sinha R K,et al. Microbial L-asparaginase:a review on current scenario and future prospects. International Journal Pharmaceutical Sciences and Research,2012,3(9):3076-3090.
[8]   Pieters R,Hunger S P,Boos J,et al. L-asparaginase treatment in acute lymphoblastic leukemia. Cancer,2011,117(2):238-249.
[9]   Prihanto A A,Wakayama M. Marine microorganism:an underexplored source of L-asparaginase. Advances in Food and Nutrition Research,2016,79:1-25.
[10]   Cedar H,Schwartz J H. Production of L-asparaginase Ⅱ by Escherichia coli. Journal of Bacteriology,1968,96(6):2043-2048.
[11]   Jennings M P,Beacham I R.Analysis of the Escherichia coli gene encoding L-asparaginase Ⅱ,ansB,and its regulation by cyclic AMP receptor and FNR proteins. Journal of Bacteriology,1990,172(3):1491-1498.
[12]   Younes G,Alireza E,Sara R A,et al. An optimized medium for screening of L-asparaginase production by Escherichia coli. American Journal of Biochemistry and Biotechnology,2008,4(4):422-424.
[13]   Varalakshmi V,Raju K J. Optimization of L-asparaginase production by Aspergillus terreus MTCC 1782 using bajra seed flour under solid state fermentation. International Journal of Research in Engineering and Technology,2013,2(9):121-129.
[14]   Vijay B,Raju K J. Production of L-asparaginase by Aspergillus terreus MTCC 1782 under solid state fermentation using pearl millet and finger millet as mixed substrate. Journal of Chemical,Biological and Physical Sciences,2015,5(1):366-377.
[15]   Khushoo A,Pal Y,Mukherjee K J. Optimization of extracellular production of recombinant asparaginase in Escherichia coli in shake-flask and bioreactor. Appl Microbiol Biotechnol,2005,68(2):189-197.
[16]   Shokri A,Sanden A M,Larsson G. Growth rate-dependent changes in Escherichia coli membrane structure and protein leakage. Appl Microbiol Biotechnol,2002,58(3):386-392.
[17]   Aghaeepoor M,Mozafari S,Shahrakl M K,et al. High level of extracellular fermentation and alternative purification of Escherichia coli Asparaginase Ⅱ. Biharean Biologist,2011,5(2):96-101.
[18]   Upadhyay A K,Singh A,Mukherjee K J,et al. Refolding and purification of recombinant L-asparaginase from inclusion bodies of E.coli into activetetrameric protein. Frontiers in Microbiology,2014,5:486.
[19]   Ghoshoon M B,Berenjian A,Hemmati S,et al. Extracellular production of recombinant L-asparaginase Ⅱ in Escherichia coli:medium optimization using response surface methodology. International Journal of Peptide Research and Therapeutics,2015,21(4):487-495.
[20]   Zhang K,Su L Q,Duan X G,et al. High-level extracellular protein production in Bacillus subtilis using an optimized dual-promoter expression system. Microbial Cell Factories,2017,16(1):32.
[21]   Feng Y,Liu S,Jiao Y,et al. Enhanced extracellular production of L-asparaginase from Bacillus subtilis 168 by B. Subtilis WB600 through a combined strategy. Applied Microbiology and Biotechnology,2017,101(4):1509-1520.
[22]   Doriya K,Kumar D S. Isolation and screening of L-asparaginase free of glutaminase and urease from fungal sp. Biotech,2016,6(2):239.
[23]   Ferrara M A,Severino N M,Mansure J J,et al. Asparaginase production by a recombinant Pichia pastoris strain harbouring Saccharomyces cerevisiae ASP3 gene. Enzyme and Microbial Technology,2006,39(7):1457-1463.
[24]   Facchinetti C G,Gonçalves R S,Sobral R S,et al. Saccharomyces cerevisiae asparaginase Ⅱ,a potential antileukemic drug:Purification and characterization of the enzyme expressed in Pichia pastoris. Protein Expression and Purification,2016,120:118-125.
[25]   Costa I M,Schultz L,Araujo B P,et al. Recombinant L-asparaginase 1 from Saccharomyces cerevisiae:an allosteric enzyme with antineoplastic activity. Scientific Reports,2016,6:36239.
[26]   Pourhossein M,Korbekandi H. Cloning,expression,purification and characterisation of Erwinia carotovora L-asparaginase in Escherichia coli. Advanced Biomedical Research,2014,3:82.
[27]   Chityala S,Venkata D V,Ahmad J,et al. High yield expression of novel glutaminase free L-asparaginase Ⅱ of Pectobacterium carotovorum MTCC 1428 in Bacillus subtilis WB800N. Bioprocess and Biosystems Engineering,2015,38(11):2271-2284.
[28]   Meena B,Anburajan L,Vinithkumar N V,et al. Molecular expression of l-asparaginase gene from Nocardiopsis alba NIOT-VKMA08 in Escherichia coli:A prospective recombinant enzyme for leukaemia chemotherapy. Gene,2016,590(2):220-226.
[29]   Lee S J,Lee Y,Park G H,et al. A newly identified glutaminase-free L-asparaginase (L-ASPG86) from the marine bacterium Mesoflavibacter zeaxanthinifaciens. Journal of Microbiology and Biotechnology,2016,26(6):1115-1123.
[30]   Nagarajan A,Thirunavukkarasu N,Suryanarayanan T S,et al. Screening and isolation of novel glutaminase free L-asparaginase from fungal endophytes. Research Journal of Microbiology,2014,9(4):163-176.
[31]   Xu F,Oruna C M,Elmore J S. The use of asparaginase to reduce acrylamide levels in cooked food. Food Chemistry,2016,210:163-171.
[32]   Zyzak D V,Sanders R A,Stojanovic M,et al. Acrylamide formation mechanism in heated foods. Journal of Agricultural and Food Chemistry,2003,51(16), 4782-4787.
[33]   Jia M,Xu M,He B,et al. Cloning,expression,and characterization of L-asparaginase from a newly isolated Bacillus subtilis B11-06. Journal of Agricultural and Food Chemistry,2013,61(39):9428-9434.
[34]   Hong S J,Lee Y H,Khan A R,et al. Cloning,expression,and characterization of thermophilic L-asparaginase from Thermococcus kodakarensis KOD1. Journal of Basic Microbiology,2014,54(6):500-508.
[35]   Huang L,Liu Y,Sun Y,et al. Biochemical characterization of a novel L-asparaginase with low glutaminase activity from Rhizomucor miehei and its application in food safety and leukemia treatment. Applied and Environmental Microbiology,2014,80(5):1561-1569.
[36]   Song P,Wang Z,Zhang X,et al. The role of autophagy in asparaginase-induced immune suppression of macrophages. Cell Death & Disease,2017,8(3):e2721.
[37]   Sakaguchi S,Higa T,Suzuki M,et al. Prophylactic use of octreotide for asparaginase-induced acute pancreatitis. International Journal of Hematology, 2017:1-3.
[38]   Bahreini E,Aghaiypour K,Abbasalipourkabir R,et al. Preparation and nanoencapsulation of L-asparaginase Ⅱ in chitosan-tripolyphosphate nanoparticles and in vitro release study. Nanoscale Research Letters,2014,9(1):340.
[39]   Baskar G,Chandhuru J,Sheraz F K,et al. Anticancer activity of fungal L-asparaginase conjugated with zinc oxide nanoparticles. Journal of Materials Science-Materials in Medicine,2015,26(1):5380.
[40]   Kim K,Jeong J H,Lim D,et al. L-Asparaginase delivered by Salmonella typhimurium suppresses solid tumors. Molecular Therapy Oncolytics,2015,2(C):15007.
[41]   Wang Y,Qian S,Meng G,et al. Cloning and expression of L-asparaginase gene in Escherichia coli.Applied Biochemistry and Biotechnology,2001,95(2):93-101.
[42]   Roth G,Nunes J E,Rosado L A,et al. Recombinant Erwinia carotovora L-asparaginase Ⅱ production in Escherichia coli fed-batch cultures. Brazilian Journal of Chemical Engineering,2013,30(2):245-256.
[1] YUAN Xiao-jing,YIN Hai-meng,FAN Xiao-wei,HE Jun-lin,HAO Shi-lei,JI Jin-gou. Preparation and Wound Repair of Keratin/Sodium Alginate/Polyacrylamide Hydrogel Skin Dressing[J]. China Biotechnology, 2021, 41(8): 17-24.
[2] CHEN Su-fang,XIA Ming-yin,ZENG Li-yan,AN Xiao-qin,TIAN Min-fang,PENG Jian. Recombinant Expression and Detection of Antimicrobial Activity of Cec4a[J]. China Biotechnology, 2021, 41(10): 12-18.
[3] LE Yi-lin,FU Yu,NI Li,SUN Jian-zhong. Expression and Characterization of a Thermostable Pyruvate Ferredoxin Oxidoreductase from the Hyperthermophile Thermotoga neapolitana and Its Application in Acetyl-CoA Production[J]. China Biotechnology, 2020, 40(3): 72-78.
[4] XUE Rui,YAO Lin,WANG Rui,LUO Zheng-shan,XU Hong,LI Sha. Advances and Applications of Recombinant Mussel Foot Proteins[J]. China Biotechnology, 2020, 40(11): 82-89.
[5] HAN Ting-han,ONG Xue-mei,ING Ya-fang,U Chen,ZHANG Kun-xiao,AO song,U Heng-hao. Cloning, Expression and Characterization of a Heat-Labile Uracil-DNA lycosylase from Scophthalmus maximus[J]. China Biotechnology, 2019, 39(10): 34-43.
[6] RAO Jing-jing, JING Yi-xian, ZOU Ming-yue, HU Xiao-lei, LIAO Fei, YANG Xiao-lan. Clone, Expression and Characterization of the Uricase from Meyerozyma guilliermondii[J]. China Biotechnology, 2017, 37(11): 74-82.
[7] ZHAO Yi-jin, WANG Teng-fei, WANG Jun-qing, WANG Rui-ming. Surface Display of Tres Using CotC as a Molecular Vector on Bacillus subtilis Spores[J]. China Biotechnology, 2017, 37(1): 71-80.
[8] LI Meng-yue, WANG Teng-fei, WANG Jun-qing, ZHAO Yi-jin, CHENG Cheng, WANG Rui-ming. Expression of Trehalose Synthase Gene in Pichia pastoris[J]. China Biotechnology, 2016, 36(2): 73-80.
[9] DING Yi, WU Hai-ying, SHI Ji-ping, SUN Jun-song. Current Progress in Recombinant Systems for Expression of Hydrogenases[J]. China Biotechnology, 2015, 35(5): 109-118.
[10] YANG Bo, CHEN Hai-qin, SONG Yuan-da, ZHANG Hao, CHEN Wei. Study of the Enzymatic Function of Myosin Cross Reactive Antigen from Bifidobacterium animalis[J]. China Biotechnology, 2012, 32(12): 30-36.
[11] GAO Bing-miao, LI Bao-zhu, WU Yong, LIN Bo, ZHU Xiao-peng, ZHANGSUN Dong-ting, LUO Su-lan. Expression, Purification and Identfication of Recombinant Conotoxin GeXIVAWT[J]. China Biotechnology, 2012, 32(09): 34-40.
[12] . Proteomic analysis of ischemic postconditioning on rabbit myocardium with Two Dimensional Polyacrylamide Gel Electrophoresis.[J]. China Biotechnology, 2010, 30(07): 0-0.
[13] WEI Hai-Chao, ZHANG Yan, FAN Yao-Chun, LI Chuan-Yi, WEN Yu-Ling, CHEN Yuan-Ding. Expression of NSP1 of a Group A Human Rotavirus and Immunological Properties[J]. China Biotechnology, 2010, 30(03): 15-21.
[14] Kun CAI Jun YIN Hui WANG. The Recombinant Expression and Receptor-binding activity of the B subunit of Shiga-like toxin type Ⅱ[J]. China Biotechnology, 2008, 28(10): 23-27.
[15] . Progress in the Study of Heparinases[J]. China Biotechnology, 2007, 27(8): 116-124.